GPLD1 and neoplasm: Among these inhibitors, 5-fluoro-2-indolyldes-chlorohalopemide (FIPI), firstly synthesized in 2007 [24], has been widely applied in anti-tumor growth and anti-metastasis via inhibiting PLD associated signal pathways [13, 14, 16, 25, 26].